SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Intestinal helminth co-infection is an unrecognised risk factor for increased pneumococcal carriage density and invasive disease.

Law, AE; Shears, RK; Lopez Rodas, AA; Grencis, RK; Cooper, PJ; Neill, DR; Kadioglu, A (2021) Intestinal helminth co-infection is an unrecognised risk factor for increased pneumococcal carriage density and invasive disease. Sci Rep, 11 (1). p. 6984. ISSN 2045-2322 https://doi.org/10.1038/s41598-021-86508-4
SGUL Authors: Cooper, Philip John

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Microsoft Word (.docx) (Supplementary Information) Published Version
Available under License Creative Commons Attribution.

Download (2MB)

Abstract

Infection with Streptococcus pneumoniae is the leading cause of death in children and burden of disease is greatest where helminth infections are also common. We investigated the impact of intestinal helminth co-infection on pneumococcal carriage; a risk factor for invasive disease. We used a mouse co-infection model and clinical data to assess the impact of co-infection on carriage density. Co-infection in mice was associated with increased pneumococcal carriage density and dissemination into lungs. Helminth-infected children also exhibited increased carriage density as compared to uninfected children. Anthelmintic treatment may be a cost-effective method of reducing pneumococcal disease burden in lower-income countries.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2021
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Sci Rep
ISSN: 2045-2322
Language: eng
Dates:
DateEvent
26 March 2021Published
8 February 2021Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
MR/P011284/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
088862/Z/09/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
204457/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 33772094
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113118
Publisher's version: https://doi.org/10.1038/s41598-021-86508-4

Actions (login required)

Edit Item Edit Item